在罗德岛州的全州胺和胺处方趋势,2017-2023年
Taylor J Paiva1, Benjamin D Hallowell2, Staci Fischer3
1Prescription Drug Monitoring Program (PDMP) Epidemiologist, Center for Health Data and Analysis (CHDA) at RIDOH.
Rhode Island medical journal (2013)
|September 27, 2024
概括
处方胺和胺的使用量显著增加,胺自2019年以来呈现快速增长. 了解这些趋势对于管理胺和胺至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 胺是一种麻醉剂,具有非标签治疗用途.
- 乙胺,一种胺衍生物,被FDA批准用于治疗耐药性抑郁症.
- 凯他明和埃斯凯他明处方的全州趋势需要调查.
研究的目的:
- 为了比较州范围内的胺和胺的处方趋势.
- 分析处方,处方者和患者的特征.
- 为了识别胺和胺之间的人口和支付差异.
主要方法:
- 使用的处方药监测计划 (PDMP) 数据从2017-2023.
- 比较胺和胺的处方,患者人口统计和处方者的特征.
- 分析了处方表格,支付方式和州外处方.
主要成果:
- 自2017年以来,胺的处方,患者和提供者分别增加了55.8%,30.6%和2.8%.
- 自2019年以来,石化的处方数量增加了1289.4%.
- 在2023年,胺主要是口袋外 (83.9%) 和粉末形式 (98.7%),而胺是保险支付 (80.2%). 自2022年以来,州外胺药物处置量增加了22%.
结论:
- 胺和胺的处方正在上升,反映了对心理健康治疗的需求增加.
- 胺胺和胺胺之间在支付方法和处方表格上存在显著差异.
- 监测胺和胺使用量对于减轻潜在的不良事件和为公共卫生战略提供信息至关重要.
更多相关视频
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
12.0K
06:58Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
19.1K
相关概念视频
01:24Parenteral Anesthetics: Overview
107
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
107
01:30Electroconvulsive Therapy
28
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
28
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
2
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
2
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
151
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
151
01:11Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
436
All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
436